ICD-11 classes
X Extension Codes
Substances
Medicaments
Agents primarily affecting blood constituents and immune...
Antineoplastic agents
XM1JG6 Monoclonal antibodies and antibody drug conjugates
XM9ND9 Programmed cell death protein 1/death ligand 1...
XM2KA7 Retifanlimab
ICD-11 XM2KA7 Retifanlimab
The diagnosis has no description.
The diagnosis includes nothing.
The diagnosis excludes nothing.
It has no clarifying diagnoses.
The diagnosis is coded elsewhere: